臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 76-100 of 309 (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-04T06:12:08Z	Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy	Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:07Z	Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling	Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:07Z	Boceprevir for chronic HCV genotype 1 infection [2]	Hsu, C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:05Z	Alpha-fetoprotein in chronic hepatitis C	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:04Z	Hepatitis C virus and lipid profiles: More questions than answers?	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:01Z	Impact of hepatitis B virus infection on metabolic profiles and modifying factors	Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:59Z	Management of hepatitis C virus infection in the genomic era	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:58Z	Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk	Wang C.-C.; Tseng T.-C.; Hsieh T.-C.; Hsu C.-S.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:56Z	Genomic variation-guided management in chronic hepatitis C	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:56Z	Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:55Z	Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals	Liu C.-J.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir	Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:53Z	IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:50Z	Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients	Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:46Z	Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan	Hsu C.-S.; JIA-HORNG KAO; Chao Y.-C.; Lin H.H.; Fan Y.-C.; Huang C.-J.; Tsai P.-S.
臺大學術典藏	2021-09-04T06:11:46Z	Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients	Hsu C.-S.; Huang C.-J.; JIA-HORNG KAO; Lin H.H.; Chao Y.-C.; Fan Y.-C.; Tsai P.-S.
臺大學術典藏	2021-09-04T06:11:43Z	Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis	Wang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin	Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:28Z	Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection	Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:26Z	Systematic review: Impact of interferon-based therapy on HCV-related hepatocellular carcinoma	Hsu C.-S.; Chao Y.-C.; Lin H.H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:19Z	HIV/HCV coinfection in Taiwan	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:15Z	Management of hepatitis C patients with decompensated liver disease	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:13Z	Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy	Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:07Z	Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway	Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S.

Showing items 76-100 of 309 (13 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2822924
	???header.visitor??? : 30072080 ???header.onlineuser??? : 1186 ???header.sponsordeclaration???